Literature DB >> 20528693

CRISPR/Cas system and its role in phage-bacteria interactions.

Hélène Deveau1, Josiane E Garneau, Sylvain Moineau.   

Abstract

Clustered regularly interspaced short palindromic repeats (CRISPRs) along with Cas proteins is a widespread system across bacteria and archaea that causes interference against foreign nucleic acids. The CRISPR/Cas system acts in at least two general stages: the adaptation stage, where the cell acquires new spacer sequences derived from foreign DNA, and the interference stage, which uses the recently acquired spacers to target and cleave invasive nucleic acid. The CRISPR/Cas system participates in a constant evolutionary battle between phages and bacteria through addition or deletion of spacers in host cells and mutations or deletion in phage genomes. This review describes the recent progress made in this fast-expanding field.

Mesh:

Year:  2010        PMID: 20528693     DOI: 10.1146/annurev.micro.112408.134123

Source DB:  PubMed          Journal:  Annu Rev Microbiol        ISSN: 0066-4227            Impact factor:   15.500


  223 in total

1.  Structure of the Cmr2 subunit of the CRISPR-Cas RNA silencing complex.

Authors:  Alexis I Cocozaki; Nancy F Ramia; Yaming Shao; Caryn R Hale; Rebecca M Terns; Michael P Terns; Hong Li
Journal:  Structure       Date:  2012-03-07       Impact factor: 5.006

2.  Mature clustered, regularly interspaced, short palindromic repeats RNA (crRNA) length is measured by a ruler mechanism anchored at the precursor processing site.

Authors:  Asma Hatoum-Aslan; Inbal Maniv; Luciano A Marraffini
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-12       Impact factor: 11.205

3.  Facilitation of CRISPR adaptation.

Authors:  Stephen T Abedon
Journal:  Bacteriophage       Date:  2011-05-01

Review 4.  RNA-guided genetic silencing systems in bacteria and archaea.

Authors:  Blake Wiedenheft; Samuel H Sternberg; Jennifer A Doudna
Journal:  Nature       Date:  2012-02-15       Impact factor: 49.962

5.  Structure and activity of the Cas3 HD nuclease MJ0384, an effector enzyme of the CRISPR interference.

Authors:  Natalia Beloglazova; Pierre Petit; Robert Flick; Greg Brown; Alexei Savchenko; Alexander F Yakunin
Journal:  EMBO J       Date:  2011-10-18       Impact factor: 11.598

6.  Molecular memory of prior infections activates the CRISPR/Cas adaptive bacterial immunity system.

Authors:  Kirill A Datsenko; Ksenia Pougach; Anton Tikhonov; Barry L Wanner; Konstantin Severinov; Ekaterina Semenova
Journal:  Nat Commun       Date:  2012-07-10       Impact factor: 14.919

Review 7.  Impact of CRISPR immunity on the emergence and virulence of bacterial pathogens.

Authors:  Asma Hatoum-Aslan; Luciano A Marraffini
Journal:  Curr Opin Microbiol       Date:  2013-12-29       Impact factor: 7.934

8.  Crystal structure of Cas9 in complex with guide RNA and target DNA.

Authors:  Hiroshi Nishimasu; F Ann Ran; Patrick D Hsu; Silvana Konermann; Soraya I Shehata; Naoshi Dohmae; Ryuichiro Ishitani; Feng Zhang; Osamu Nureki
Journal:  Cell       Date:  2014-02-13       Impact factor: 41.582

9.  The three major types of CRISPR-Cas systems function independently in CRISPR RNA biogenesis in Streptococcus thermophilus.

Authors:  Jason Carte; Ross T Christopher; Justin T Smith; Sara Olson; Rodolphe Barrangou; Sylvain Moineau; Claiborne V C Glover; Brenton R Graveley; Rebecca M Terns; Michael P Terns
Journal:  Mol Microbiol       Date:  2014-06-04       Impact factor: 3.501

10.  Role of the Streptococcus mutans CRISPR-Cas systems in immunity and cell physiology.

Authors:  M A Serbanescu; M Cordova; K Krastel; R Flick; N Beloglazova; A Latos; A F Yakunin; D B Senadheera; D G Cvitkovitch
Journal:  J Bacteriol       Date:  2014-12-08       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.